Xenotransplantation Market Report 2026

Xenotransplantation Market Overview

• Xenotransplantation market size has reached to $15.77 billion in 2025 • Expected to grow to $23.51 billion in 2030 at a compound annual growth rate (CAGR) of 8.2% • Growth Driver: Role Of Increase In Demand For Tissue And Organ Transplantation On Xenotransplantation Market • Market Trend: Strategic Partnership For Advancing Xenotransplantation With Karius And Egenesis Join Forces To Address Organ Shortage • North America was the largest region in 2025.

What Is Covered Under Xenotransplantation Market?

Xenotransplantation is a procedure in which live nonhuman animal cells, tissues, or organs are transplanted, implanted, or infused into a human recipient. It also involves the transplantation, implantation, or infusion of human body fluids, cells, tissues, or organs after having had ex vivo contact with living nonhuman animal cells, tissues, or organs. The main products of xenotransplantation are organ preservation solutions, transplant diagnostics, and tissue products. The organ preservation solutions reduce ischemic and hypoxic damage during cold storage and enhance graft survival. Organ preservation techniques such as machine perfusion, in situ core cooling, and organ preservation fluids are all included in this field. Treatments for xenotransplantation include analgesics, immunosuppressants, and other treatments that apply to the heart, kidney, and other organs. The end-users of xenotransplantation include hospitals, transplant centers, and other end-users.

What Is The Xenotransplantation Market Growth Forecast?

The xenotransplantation market size is expected to see strong growth in the next few years. It will grow to $23.51 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing clinical trial activity in xenotransplantation, rising investments in gene-editing technologies, growing collaboration between biotech firms and hospitals, expansion of ethical and regulatory acceptance, increasing demand for alternative organ sources. Major trends in the forecast period include increasing research in genetically modified donor organs, growing focus on immune rejection mitigation, expansion of advanced organ preservation technologies, rising investment in translational transplant research, improved regulatory frameworks for clinical trials.

What Is The Driver Of The Xenotransplantation Market?

The increase in demand for tissue and organ transplantation is expected to propel the xenotransplantation market. A hereditary disorder like polycystic kidney disease, cystic fibrosis, or a heart malfunction might lead to the need for an organ transplant in a large number of people. The high demand for organ transplants has led to a shortage of organs. Xenotransplantation helps deal with this shortage by using nonhuman organs instead of human organs. For instance, in January 2024, according to the Organ Procurement and Transplantation Network, a US-based Department of Health and Human Services program responsible for overseeing the nation’s organ donation and transplantation system, organ transplants from living and deceased donors totalled 46,632 in 2023, reflecting an 8.7 percent increase compared with 2022. Of these, 39,679 procedures were from deceased donors, representing an 8.9 percent rise over the previous year. Therefore, the increasing demand for tissue and organ transplantation will drive the xenotransplantation industry.

Key Players In The Global Xenotransplantation Market

Major companies operating in the xenotransplantation market are United Therapeutics, Preservation Solutions, OrganOX Limited, Talaris Therapeutics, TransMedic Inc., Sernova Corp, Nova Lung, Recombinetics, Tissue Regenix, TissueGene, SAB Biotherapeutics, eGenesis, Revivicor, Organ Recovery Systems, CRISPR Therapeutics, Qihan Biotech, Sino-Clone Organ Biotechnology, Xenothera, Lung Biotechnology.

Global Xenotransplantation Market Trends and Insights

Major companies operating in the xenotransplantation market are focusing on strategic partnerships to provide reliable services to customers. A strategic partnership is an arrangement between two or more companies or organizations that helps each other or works together to achieve their respective goals. For instance, in April 2023, Karius, a US-based company and the world leader in liquid biopsy for infectious diseases, partnered with eGenesis, Inc., a US-based biotechnology company pioneering xenotransplantation, to develop human-compatible organs and cells for the treatment of organ failure. This partnership will relieve the organ shortage and accelerate the availability of safe xenotransplantation. Karius intends to utilize its platform to facilitate the identification and measurement of diseases that may be present in organ donors from pigs. The main goal of the collaboration is to build a more comprehensive testing platform for the identification of microbial cell-free DNA, which will be the foundation for surveillance and monitoring both before and after transplantation.

What Are Latest Mergers And Acquisitions In The Xenotransplantation Market?

In October 2023, United Therapeutics Corporation, a US-based biotechnology company, acquired Miromatrix Medical for $91 million. This acquisition aims to increase the scope of its ongoing organ production initiatives, including xenotransplantation, 3-D bioprinting, x-vivo lung perfusion, and regenerative medicine techniques. Miromatrix Medical is a US-based development-stage, fully implantable, manufactured kidney product.

What Defines the Xenotransplantation Market?

The xenotransplantation market includes revenues earned by entities by providing transplantation and diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Xenotransplantation Market Report 2026?

The xenotransplantation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the xenotransplantation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.